Econ Market Research
Econ Market Research Report Cover

Incontinence And Ostomy Care Products Market

Incontinence And Ostomy Care Products Market Size, Share, Trends, Growth, and Industry Analysis, By Product Type, By Disease Type, By Application, By End User, Regional Analysis and Forecast Period 2026-2035.

Last Updated:
Oct 27, 2026
Base year:
2025
Historical Data:
2022 - 2024
Region:
Global
Pages:
150+
Report Format:
PDF + Excel
Report ID:
EMR002762

Forecast Period

2026 - 2035

CAGR

4.9%

2025 Market Size

US$ 18.02 Billion

2026 Market Size

US$ 18.9 Billion

2035 Market Size

US$ 29.07 Billion

Incontinence And Ostomy Care Products Market Overview

As per Econ Market Research analysis, the Global Incontinence And Ostomy Care Products Market was valued at approximately US$ 18.9 Billion in 2026 and is predicted to reach US$ 29.07 Billion by 2035, expanding at a CAGR of 4.9% over the forecast duration. The base year is 2025.

The global Incontinence And Ostomy Care Products Market serves individuals who require bladder management, bowel diversion support, and specialized personal hygiene products. The industry combines absorbent incontinence products with medical-grade ostomy pouching systems, skin barriers, adhesives, and associated accessories. Global population ageing is an important underlying demand factor, with the United Nations reporting 1.22 billion people aged 60 years or older in 2025. Manufacturers must address different care requirements because absorbent products are frequently purchased through consumer and institutional channels, while ostomy products often require individualized clinical assessment.

The United States has an established care infrastructure supported by hospitals, specialist nurses, home medical equipment providers, pharmacies, and distributors. United Ostomy Associations of America identifies between 725,000 and 1 million people living with an ostomy or continent diversion in the country. Medicare coverage arrangements recognize the continuing need for suitable ostomy supplies, with product eligibility and quantities linked to medical necessity. These conditions create an organized supply environment in which prescription documentation, patient assessment, and continuity of product availability influence purchasing decisions.

Incontinence And Ostomy Care Products Market size and forecast chart showing growth from US$ 18.9 Billion in 2026 to US$ 29.07 Billion by 2035 at a CAGR of 4.9%.
Incontinence And Ostomy Care Products Market size forecast, 2026-2035

The European market operates through national healthcare systems, medical appliance suppliers, specialist clinical services, and consumer retail networks. In England, government dispensing records identified 1,299,650 community prescription items specifically named as colostomy or ileostomy appliances during 2023–2024. These records illustrate the importance of established prescribing and reimbursement channels, although they do not represent the complete European ostomy product market. European suppliers must also address differences in national reimbursement lists, approved products, dispensing practices, and consumer preferences, making market access dependent on both clinical suitability and local procurement arrangements.

Connected continence management technologies are changing how some professional caregivers monitor product utilization and individual care requirements. Reusable moisture-monitoring sensors can notify caregivers when absorbent products require attention, helping replace purely schedule-based checking with more individualized care decisions. Wearable bladder-monitoring technologies are also being investigated for their ability to identify bladder filling patterns and support timely toileting. These solutions are particularly relevant in assisted living environments, where caregivers must balance resident comfort, clinical observation, and available staffing resources.

Discretion and everyday usability have become important product design considerations alongside absorbency performance. Manufacturers are developing thinner absorbent structures, softer materials, breathable outer layers, flexible waistbands, and designs that resemble conventional underwear. Ostomy product preferences similarly reflect the importance of low-profile pouches, comfortable textile coverings, and systems that accommodate different body shapes. Product differentiation increasingly depends on how effectively a device performs during walking, sitting, sleeping, and other routine activities rather than on laboratory absorbency measurements alone.

Digital ordering and support services represent another change in customer engagement. Specialist suppliers can provide product guidance, reorder assistance, educational resources, and communication with care teams through online channels. Manufacturers are also examining packaging efficiency, responsible material selection, and reduced production waste as sustainability expectations influence institutional procurement. However, environmental improvements must be evaluated against hygiene requirements, product integrity, and the clinical limitations of reusable or alternative-material solutions.

Incontinence And Ostomy Care Products Market Dynamics

The Incontinence And Ostomy Care Products Market is influenced by healthcare needs, consumer purchasing behavior, medical reimbursement structures, and manufacturer capabilities. Incontinence products are purchased for personal management and professional care, whereas ostomy products form part of continuing treatment following specific surgical procedures. Consequently, the market contains different purchasing models, from everyday retail transactions to specialist medical supply arrangements. Product performance must be considered alongside affordability, correct usage, and availability. Manufacturers and distributors therefore need different commercial and service capabilities to support the requirements of consumers, healthcare facilities, prescribing professionals, and individuals managing long-term conditions.

Drivers of Market Growth

Increasing prevalence of urinary incontinence and associated long-term care requirements.

Urinary incontinence is an important driver because it creates an ongoing need for appropriate absorbent products and supporting hygiene supplies. A study published in 2026, using United States national survey data collected between 2015 and 2020, identified symptomatic urinary incontinence in 22.3% of nonpregnant adult women. The condition may arise from several clinical and physiological factors, including pelvic floor dysfunction, neurological disorders, pregnancy-related changes, and age-associated health conditions. Product requirements vary according to the severity and frequency of leakage, personal mobility, and the ability to manage toileting independently. These differences support demand for multiple absorbency levels, fastening systems, and product formats rather than a uniform solution for all users.

Market Restraints

Affordability limitations and inconsistent access to appropriate care products.

Product affordability remains a significant restraint, particularly when individuals require continuous supplies but have limited insurance coverage or household resources. Reimbursement arrangements differ between healthcare systems, and coverage may depend on product classification, eligibility rules, documentation, and approved supply quantities. Consumers purchasing incontinence products without financial assistance may choose lower-priced alternatives even when a different design would better meet their needs. Ostomy users can face additional difficulties when a preferred pouch or skin barrier is unavailable through an approved supplier. These constraints make affordability, reimbursement navigation, and dependable distribution important considerations for manufacturers seeking broader product accessibility.

Market Opportunities

Expansion of specialist home-based care and personalized product support.

Home-based care creates opportunities for suppliers that can combine appropriate products with accessible clinical guidance and reliable delivery services. Individuals transitioning from hospital treatment may need assistance in selecting supplies, establishing routines, and identifying changes that require professional reassessment. Specialist ostomy nurses can help patients understand pouch fitting, skin protection, and the practical use of accessories after discharge. Suppliers offering structured follow-up services can strengthen the relationship between clinical recommendations and actual product use. Commercial opportunities also exist in coordinated care models that connect hospitals, community clinicians, medical equipment providers, and patients without requiring repeated hospital visits for routine supply management.

Market Challenges

Preventing skin complications while accommodating diverse individual requirements.

Skin protection presents a continuing challenge because prolonged moisture exposure, friction, unsuitable adhesives, and repeated product removal can contribute to irritation. Incontinence-associated dermatitis requires attention to cleansing practices, absorbent product selection, and the condition of the skin. For ostomy users, changes in abdominal contours or stoma characteristics can interfere with pouch adhesion and increase the likelihood of leakage. Manufacturers must therefore balance absorbency, breathability, adhesive security, and gentle removal across a wide range of user needs. Clinical evaluation and appropriate fitting remain essential because product specifications alone cannot guarantee satisfactory performance for every individual.

Incontinence And Ostomy Care Products Market SWOT Analysis

Strengths

  • Recurring product requirements: Many users require continuous access to consumable care products, supporting an established pattern of repeat purchasing through appropriate supply channels.

  • Established clinical applications: Ostomy pouching systems and protective incontinence products address recognized healthcare needs with clear functional requirements.

  • Broad product specialization: The market includes different absorbency levels, pouch configurations, skin protection materials, and support accessories that allow manufacturers to serve distinct customer requirements.

  • Multiple distribution channels: Consumer retailers, institutional suppliers, pharmacies, and specialist medical equipment providers create diversified routes to customers.

Weaknesses

  • Complex product selection: Choosing suitable products may require professional guidance, particularly when individual skin conditions or physical characteristics complicate fitting.

  • Dependence on consumables: Many products require frequent replacement, creating recurring purchasing and inventory responsibilities for users and caregivers.

  • Limited interchangeability: Differences in product dimensions, adhesives, closures, and personal tolerance can make switching between brands difficult.

  • Uneven customer awareness: Limited understanding of available product choices may prevent individuals from identifying solutions suited to their daily activities.

Opportunities

  • Specialized clinical education: Training programs can improve product knowledge among healthcare professionals and strengthen appropriate product selection.

  • Accessible product information: Clear instructions, multilingual educational materials, and accessible packaging can help users manage supplies independently.

  • Inclusive product design: Products adapted for limited hand dexterity, visual impairment, or reduced mobility can address underserved functional needs.

  • Improved procurement tools: Digital inventory management and forecasting systems can help institutions reduce supply mismatches and unnecessary stockholding.

Threats

  • Raw material volatility: Fluctuations in absorbent polymer, nonwoven fabric, packaging, and adhesive material availability can affect manufacturing operations.

  • Regulatory noncompliance: Failure to meet applicable quality, safety, labeling, or medical device requirements can restrict product distribution.

  • Counterfeit and unsuitable products: Unverified supplies may expose users to inconsistent performance and undermine confidence in legitimate brands.

  • Procurement concentration: Large institutional purchasing organizations can exert substantial pressure on suppliers over contractual terms and product selection.

Incontinence And Ostomy Care Products Market Segmentation Analysis

The Incontinence And Ostomy Care Products Market is segmented by product type, disease type, application, and end user. These classifications reflect differences in clinical needs, product functionality, purchasing behavior, and care environments. Product-type analysis distinguishes absorbent personal care products from specialized ostomy supplies, while disease-type analysis examines the underlying conditions associated with product use. Application analysis evaluates the principal functions of different solutions, and end-user analysis identifies the institutions and care settings responsible for selecting or administering them. These dimensions provide a framework for examining demand without treating overlapping clinical applications as independent patient populations.

By Product Type

Incontinence care products include adult diapers and briefs, protective underwear, incontinence pads and liners, absorbent underpads, and incontinence skin care products. Adult diapers and briefs provide higher-coverage protection for users requiring assistance or managing substantial leakage, while protective underwear is designed for pull-on convenience. Pads and liners support lighter protection requirements, and underpads protect bedding and furniture. Skin care products complement absorbent materials through cleansing and protective functions.

Ostomy care products include ostomy bags and pouching systems, skin barriers and adhesives, stoma care accessories, and support belts and garments. Pouching systems are central to collecting bodily output, while barriers establish the interface between the device and surrounding skin. Accessories and supportive garments address supplementary comfort, fitting, and management needs.

By Disease Type

Crohn's disease and ulcerative colitis are inflammatory bowel diseases that may require surgical treatment and temporary or permanent ostomy formation in selected patients. Crohn's disease can affect different portions of the gastrointestinal tract, while ulcerative colitis primarily involves the colon and rectum. Their associated product requirements depend on the surgical procedure performed and the resulting diversion.

Cancer represents another important disease category, particularly when treatment of colorectal or bladder malignancies requires bowel or urinary diversion. Patients may need ostomy products during recovery or as part of permanent postoperative management. Urinary incontinence primarily supports demand for absorbent care products because the condition involves involuntary urine leakage. Product selection across these disease categories depends on clinical severity, treatment history, and individual functional requirements.

By Application

Protection and cleansing products support everyday hygiene, moisture management, and maintenance of vulnerable skin. This application includes absorbent materials and compatible cleansing solutions used in personal and institutional care environments. Effective protection requires appropriate changes and skin care practices rather than reliance on absorbency alone.

Security and leakage control represent a distinct performance requirement. Product performance depends on suitable fit, fluid containment, secure fastening, and dependable seals during movement or prolonged wear. Ostomy pouching systems additionally require appropriate adhesion around the stoma to reduce accidental leakage.

Odor control is another important application affecting comfort and confidence. Odor-management features can include pouch filters and suitable absorbent product technologies. Their effectiveness depends on product design, proper use, and timely maintenance.

By End User

Hospitals use incontinence and ostomy products across medical wards, surgical departments, rehabilitation services, and inpatient nursing environments. Clinical procurement decisions emphasize product safety, suitability, standard operating procedures, and access to necessary supplies. Hospital-based ostomy care also includes patient assessment and preparation for self-management after discharge.

Clinics provide follow-up care, continence assessments, and specialist consultations, creating requirements for appropriate clinical products and patient education. Ambulatory surgical centers may use relevant supplies during perioperative treatment and the immediate postoperative period, depending on the procedures performed.

Home care settings represent a major continuing-use environment, where patients, relatives, and professional caregivers manage daily product requirements. Ease of use, comfortable fitting, dependable delivery, and compatibility with independent living are especially important in this setting.

Regional Analysis

Regional conditions influence the Incontinence And Ostomy Care Products Market through population demographics, healthcare infrastructure, reimbursement arrangements, and product availability. Established healthcare systems generally provide more structured access to medical appliances and specialist clinical services, although coverage conditions differ. Developing healthcare markets may experience uneven access between major urban centers and underserved communities. Manufacturers must account for different regulatory procedures, distribution networks, professional training resources, and patient purchasing capabilities. Regional analysis therefore considers the practical conditions under which incontinence and ostomy care products reach consumers and healthcare institutions without assigning unsupported market-share percentages.

North America

North America has an established network of healthcare institutions, specialized distributors, pharmacies, and home medical equipment suppliers serving individuals with continence and ostomy needs. In the United States, Medicare's Ostomy Supplies Local Coverage Determination L33828 establishes medical-necessity criteria and commonly allowed supply quantities for relevant products. The framework also requires documentation supporting coverage and places conditions on recurring supply orders. These requirements make administrative accuracy and appropriate product coding important aspects of distribution.

Canada's healthcare environment involves provincial and territorial arrangements that can influence access to medical supplies and financial assistance. Coverage policies and eligibility requirements vary by jurisdiction, requiring suppliers to understand local purchasing conditions. Hospital discharge coordinators and community care providers play important roles in connecting patients with suitable ongoing supply arrangements.

The region also has a developed consumer retail environment for personal incontinence products. Manufacturers compete through product convenience, absorbency options, fit, and availability across physical and digital channels. Specialist service quality remains particularly important in the medical ostomy category.

Europe

Europe's ostomy care market is shaped by national reimbursement systems, specialist nursing services, medical device regulation, and organized pharmacy distribution. The European Union Medical Device Regulation 2017/745 establishes requirements relevant to qualifying medical devices, including safety documentation, conformity assessment, and post-market responsibilities. Manufacturers must determine the applicable classification and regulatory obligations for individual products rather than applying identical requirements to every personal hygiene item.

The European medical device identification framework also supports product traceability. Mandatory use of the relevant EUDAMED device-registration module began on May 28, 2026, strengthening the importance of accurate regulatory information for affected manufacturers. This creates operational requirements involving product records, identification systems, and regulatory coordination.

European healthcare providers also place importance on appropriate product prescribing and efficient dispensing. Specialist stoma nurses contribute to device selection and postoperative care, while community suppliers provide access to approved appliances. Environmental considerations further influence product and packaging development, although hygiene and clinical performance remain necessary requirements for product acceptance.

Asia-Pacific

Asia-Pacific includes mature medical device markets alongside healthcare systems that are expanding access to specialist products. Japan presents a significant demographic factor, with its national statistics bureau reporting that individuals aged 65 and older represented 29.6% of the population in 2026. The country's ageing population creates substantial demand for eldercare infrastructure and products supporting daily living, including continence management solutions.

China provides an extensive manufacturing environment for personal hygiene and medical consumables, supported by domestic materials processing and established industrial supply chains. Local producers and international manufacturers operate in a market with different consumer affordability levels and healthcare purchasing practices. Product quality, distribution coverage, and clinical awareness remain important differentiators.

India and Southeast Asian countries present opportunities linked to hospital development, expanding healthcare distribution, and improving awareness of specialist treatment needs. Access to dedicated stoma nurses and appropriate postoperative supplies may differ between facilities. Manufacturers entering these markets must consider local regulatory requirements, price sensitivity, and the availability of trained healthcare professionals.

Middle East & Africa

The Middle East and Africa market includes healthcare systems with substantially different infrastructure, purchasing arrangements, and specialist service availability. Gulf countries have developed hospital networks that support surgical care, medical device procurement, and access to imported healthcare products. Public and private healthcare providers influence purchasing decisions according to clinical requirements, procurement policies, and approved supply arrangements.

Across parts of Africa, access to specialized ostomy supplies can be constrained by limited distribution infrastructure, import dependence, and differences between urban and rural healthcare services. These conditions make product availability and continuity of supply important operational concerns. Local distributors and healthcare organizations may need to coordinate procurement with specialist training and patient support.

Regional manufacturers and international suppliers must also consider climate-related storage conditions, transportation reliability, and product packaging integrity. Developing appropriate distribution arrangements can improve access to essential supplies, while clinical education helps support correct product use in less specialized care environments.

Competitive Landscape

The competitive landscape includes multinational medical technology companies, absorbent hygiene manufacturers, specialist ostomy suppliers, and healthcare distribution businesses. Competition occurs across different product categories rather than through a single uniform portfolio. Essity and Kimberly-Clark have established consumer and professional incontinence product businesses, supported by recognized brands and extensive commercial distribution arrangements. Their competitive strengths include product development, retail accessibility, and the ability to supply institutional care environments.

Coloplast, Hollister, and Convatec have specialist positions in ostomy care, where clinical product performance and professional relationships strongly influence customer choice. Differentiation includes pouching configurations, skin barrier technology, accessories, patient education, and support services. The ability to accommodate varied stoma characteristics contributes to product suitability and customer retention.

ABENA, Ontex, PAUL HARTMANN, and First Quality participate in absorbent care categories through professional, institutional, private-label, or consumer-oriented offerings. Cardinal Health and Medline also support healthcare supply chains through product sourcing, distribution, and institutional customer relationships.

Competitive performance depends on dependable manufacturing, product quality, clinical credibility, and supply availability. Suppliers serving healthcare organizations must additionally demonstrate reliable documentation, order fulfillment, and compatibility with established purchasing systems. Publicly available information does not establish a consistent market-share ranking across the complete combined incontinence and ostomy care products market.

List of Top Incontinence And Ostomy Care Products Companies

  • Essity AB (Sweden)

  • Kimberly-Clark Corporation (U.S.)

  • Attends Healthcare Products Inc. (U.S.)

  • ABENA A/S (Denmark)

  • Coloplast A/S (Denmark)

  • Ontex Group NV (Belgium)

  • PAUL HARTMANN AG (Germany)

  • First Quality Enterprises Inc. (U.S.)

  • Hollister Incorporated (U.S.)

  • Cardinal Health Inc. (U.S.)

  • Unicharm Corporation (Japan)

  • Convatec Group PLC (UK)

  • B. Braun SE (Germany)

  • Becton Dickinson and Company (U.S.)

  • Medline Industries LP (U.S.)

Leading Companies by Market Share

Essity AB (Sweden): Essity is a major participant in global incontinence care through its TENA brand, which serves consumer and professional healthcare channels. The company supplies absorbent care products and related services across multiple international markets. Its established product portfolio and healthcare customer relationships support its competitive position, although a comparable share of the entire combined market cannot be reliably assigned.

Coloplast A/S (Denmark): Coloplast is a leading specialist manufacturer in ostomy care, with established pouching systems and supporting accessories used internationally. Its portfolio includes the SenSura Mio platform, which provides product options for different abdominal contours and fitting requirements. Coloplast's specialist clinical focus distinguishes its business from broader absorbent hygiene manufacturers.

Consistent public company-level market-share percentages covering the same market definition, geography, and reporting period are not available for a reliable direct comparison. Therefore, no unsupported numerical market-share rankings are assigned to these companies.

Investment activity in the Incontinence And Ostomy Care Products Market involves manufacturing infrastructure, product development capabilities, supply-chain improvements, and specialized healthcare services. Absorbent product manufacturing requires equipment for nonwoven material processing, absorbent core assembly, fastening components, and packaging. Investment decisions must consider production efficiency, material utilization, and the ability to manufacture different product sizes without compromising quality. Flexible production capabilities can help suppliers respond to changing institutional contracts and retail product requirements.

Ostomy manufacturing investment has different technical priorities. Precision processing of skin barriers, pouch films, coupling systems, and adhesive materials requires controlled manufacturing conditions and consistent product validation. Companies developing specialized medical devices must also consider documentation, testing, and regulatory requirements when expanding production capabilities.

Distribution infrastructure offers additional opportunities. Warehousing improvements, inventory management technology, and coordinated delivery networks can support healthcare providers managing frequently replenished supplies. These investments are especially relevant when product shortages could interrupt essential care.

Opportunities also exist in product fitting education, rehabilitation support, and specialist healthcare partnerships. Manufacturers can collaborate with clinical professionals to improve training materials and understand unmet product requirements. Investment quality ultimately depends on whether capital deployment improves product availability, manufacturing reliability, clinical suitability, or access to appropriate care.

Product Innovation & Development

Product innovation is increasingly concerned with solving specific functional problems experienced by people using incontinence and ostomy products. Absorbent care development includes fluid acquisition layers, distribution channels, superabsorbent core structures, and breathable materials. These components must work together because total absorption capacity does not independently determine how effectively a product manages sudden fluid release. Design validation therefore needs to assess fluid intake behavior, surface dryness, leakage protection, and performance in different body positions.

In ostomy care, flexible skin barriers and contour-adaptable pouching systems address challenges associated with irregular abdominal surfaces. Convex and concave barrier configurations serve different fitting requirements, while appropriate adhesive formulations help balance secure attachment with skin tolerance. Coupling mechanisms also influence handling, particularly for users who experience difficulty aligning or fastening pouch components.

Hollister's CeraPlus product portfolio demonstrates the use of ceramide-infused skin barrier technology in ostomy care. This approach reflects the importance of protecting the skin surrounding a stoma alongside securing the pouching system.

Product engineering is also examining easier opening mechanisms, improved handling surfaces, and less conspicuous designs. These features can influence independent use and everyday comfort, particularly for individuals with limited dexterity or changing physical requirements. Effective innovation must combine material performance with usability testing and appropriate clinical evaluation.

Recent Developments (2023–2026)

  • In February 2024, Convatec Group PLC announced the launch of its Esteem Body with Leak Defense one-piece soft-convex ostomy system in Italy, expanding its offering for patients with different abdominal contours and stoma shapes.

  • In May 2024, Coloplast A/S announced the introduction of its Heylo digital leakage notification system and additional SenSura Mio ostomy products, broadening its portfolio of pouching and leakage management solutions.

  • In June 2025, Ontex Group NV launched its iD Discreet incontinence product range for European healthcare partners, introducing breathable absorbent products designed for comfort and everyday discretion.

  • In October 2025, Essity AB reported the launch of TENA ProSkin Stretch Day & Night, an incontinence product designed to simplify application and removal for patients and professional caregivers.

  • In February 2026, Ontex Group NV introduced its Sensitive adult incontinence range, incorporating product features intended to support skin comfort and protection in healthcare settings.

  • In September 2026, ABENA A/S introduced its Slip Premium M5 and L5 products, extending its incontinence care portfolio with absorbent briefs designed for rapid and high-volume bladder voiding.

Scope of the Incontinence And Ostomy Care Products Market Report

The Incontinence And Ostomy Care Products Market report examines the industry through product classification, clinical applications, end-user requirements, geographic conditions, and competitive activity. Product segmentation covers incontinence care products and ostomy care products, including their specified subcategories. Disease-type analysis evaluates Crohn's disease, ulcerative colitis, cancer, and urinary incontinence, while application coverage addresses protection and cleansing, security and leakage control, and odor control.

End-user analysis includes hospitals, clinics, ambulatory surgical centers, and home care settings. Regional coverage examines North America, Europe, Asia-Pacific, and the Middle East and Africa through healthcare infrastructure, reimbursement arrangements, product accessibility, and distribution conditions.

The report also addresses market drivers, restraints, opportunities, challenges, and SWOT characteristics. Competitive analysis reviews relevant manufacturers, their product positioning, and operational differentiation without assigning unsupported market shares. Investment analysis considers production capabilities and commercial infrastructure, while product innovation coverage evaluates materials, design, and functionality. Recent manufacturer developments are examined through identifiable announcements involving products and market participants.

Incontinence And Ostomy Care Products Market Report Scope & Segmentation

AttributesDetails
Market Size (Current)Current market valuationUS$ 18.9 Billion in 2026
Market Size (Forecast)Projected market valuationUS$ 29.07 Billion in 2035
Growth RateCompound Annual Growth RateCAGR of 4.9% from 2026 to 2035
Forecast PeriodAnalysis timeline2026 – 2035
Base YearReference year for analysis2025
Historical Data AvailablePast market data availabilityYes
Regional ScopeGeographical coverageGlobal
Segments CoveredMarket segments analyzed

By Product Type

  • Incontinence Care Products

    • Adult Diapers and Briefs

    • Protective Underwear

    • Incontinence Pads and Liners

    • Absorbent Underpads

    • Incontinence Skin Care Products

  • Ostomy Care Products

    • Ostomy Bags and Pouching Systems

    • Ostomy Skin Barriers and Adhesives

    • Stoma Care Accessories

    • Ostomy Support Belts and Garments


By Disease Type

  • Crohn's Disease

  • Ulcerative Colitis

  • Cancer

  • Urinary Incontinence


By Application

  • Protection and Cleansing

  • Security and Leakage Control

  • Odor Control


By End User

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Home Care Settings

Key Market Players

Leading companies covered in this report

  • Essity AB (Sweden)
  • Kimberly-Clark Corporation (U.S.)
  • Attends Healthcare Products Inc. (U.S.)
  • ABENA A/S (Denmark)
  • Coloplast A/S (Denmark)
  • Ontex Group NV (Belgium)
  • PAUL HARTMANN AG (Germany)
  • First Quality Enterprises Inc. (U.S.)
  • Hollister Incorporated (U.S.)
  • Cardinal Health Inc. (U.S.)
  • Unicharm Corporation (Japan)
  • Convatec Group PLC (UK)
  • B. Braun SE (Germany)
  • Becton Dickinson and Company (U.S.)
  • Medline Industries LP (U.S.)

Frequently Asked Questions

Common questions about this report

The study period covers historical insights and forecast projections for the period 2026-2035.

About the Author

Market research expert with years of industry experience

Rahul Garje

Rahul Garje

RESEARCH ASSOCIATE

I’m Rahul Garje, a Research Associate at Econ Market Research, specializing in data collection, market analysis, and supporting industry reports with accurate insights and trends.

Related Reports

Explore more market insights from the same category

Our Clients

3M logo
Accenture logo
Apyx Medical logo
Atlas Copco logo
GE General Electric logo
IBM logo
Johnson and Johnson logo
LEK Consulting logo
Leschaco logo
Medtronic logo
TruGolf logo
Wieth Medical logo
3M logo
Accenture logo
Apyx Medical logo
Atlas Copco logo
GE General Electric logo
IBM logo
Johnson and Johnson logo
LEK Consulting logo
Leschaco logo
Medtronic logo
TruGolf logo
Wieth Medical logo